S&P 500   3,234.94 (-2.55%)
DOW   26,802.10 (-3.09%)
QQQ   263.81 (-1.15%)
AAPL   107.17 (+0.31%)
MSFT   199.54 (-0.42%)
FB   246.80 (-2.27%)
GOOGL   1,421.57 (-2.03%)
AMZN   2,887.82 (-2.27%)
NVDA   491.78 (+0.86%)
TSLA   442.77 (+0.14%)
BABA   270.74 (-0.61%)
CGC   15.56 (-4.89%)
GE   6.25 (-9.16%)
MU   48.79 (-3.84%)
AMD   76.48 (+2.07%)
T   28.29 (-2.21%)
F   6.87 (-4.98%)
ACB   6.31 (-3.37%)
GILD   63.60 (-2.23%)
NFLX   478.90 (+1.90%)
DIS   124.13 (-3.50%)
BAC   24.09 (-4.44%)
BA   156.93 (-2.61%)
S&P 500   3,234.94 (-2.55%)
DOW   26,802.10 (-3.09%)
QQQ   263.81 (-1.15%)
AAPL   107.17 (+0.31%)
MSFT   199.54 (-0.42%)
FB   246.80 (-2.27%)
GOOGL   1,421.57 (-2.03%)
AMZN   2,887.82 (-2.27%)
NVDA   491.78 (+0.86%)
TSLA   442.77 (+0.14%)
BABA   270.74 (-0.61%)
CGC   15.56 (-4.89%)
GE   6.25 (-9.16%)
MU   48.79 (-3.84%)
AMD   76.48 (+2.07%)
T   28.29 (-2.21%)
F   6.87 (-4.98%)
ACB   6.31 (-3.37%)
GILD   63.60 (-2.23%)
NFLX   478.90 (+1.90%)
DIS   124.13 (-3.50%)
BAC   24.09 (-4.44%)
BA   156.93 (-2.61%)
S&P 500   3,234.94 (-2.55%)
DOW   26,802.10 (-3.09%)
QQQ   263.81 (-1.15%)
AAPL   107.17 (+0.31%)
MSFT   199.54 (-0.42%)
FB   246.80 (-2.27%)
GOOGL   1,421.57 (-2.03%)
AMZN   2,887.82 (-2.27%)
NVDA   491.78 (+0.86%)
TSLA   442.77 (+0.14%)
BABA   270.74 (-0.61%)
CGC   15.56 (-4.89%)
GE   6.25 (-9.16%)
MU   48.79 (-3.84%)
AMD   76.48 (+2.07%)
T   28.29 (-2.21%)
F   6.87 (-4.98%)
ACB   6.31 (-3.37%)
GILD   63.60 (-2.23%)
NFLX   478.90 (+1.90%)
DIS   124.13 (-3.50%)
BAC   24.09 (-4.44%)
BA   156.93 (-2.61%)
S&P 500   3,234.94 (-2.55%)
DOW   26,802.10 (-3.09%)
QQQ   263.81 (-1.15%)
AAPL   107.17 (+0.31%)
MSFT   199.54 (-0.42%)
FB   246.80 (-2.27%)
GOOGL   1,421.57 (-2.03%)
AMZN   2,887.82 (-2.27%)
NVDA   491.78 (+0.86%)
TSLA   442.77 (+0.14%)
BABA   270.74 (-0.61%)
CGC   15.56 (-4.89%)
GE   6.25 (-9.16%)
MU   48.79 (-3.84%)
AMD   76.48 (+2.07%)
T   28.29 (-2.21%)
F   6.87 (-4.98%)
ACB   6.31 (-3.37%)
GILD   63.60 (-2.23%)
NFLX   478.90 (+1.90%)
DIS   124.13 (-3.50%)
BAC   24.09 (-4.44%)
BA   156.93 (-2.61%)
Log in
OTCMKTS:GLAPY

Glanbia Stock Forecast, Price & News

$51.00
0.00 (0.00 %)
(As of 09/18/2020 08:10 PM ET)
Add
Compare
Today's Range
$51.00
Now: $51.00▼
$51.00
50-Day Range
$51.00
MA: $57.51▼
$61.32
52-Week Range
$45.48
Now: $51.00▼
$64.15
Volume118 shs
Average Volume1,878 shs
Market Capitalization$3.02 billion
P/E Ratio10.34
Dividend Yield2.39%
Beta0.15
Glanbia plc operates as a nutrition company worldwide. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, the Internet, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment manufactures and sells cheese, dairy and non-dairy nutritional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment operates as a milk processor in Ireland; and produces a range of value added dairy ingredients and consumer products. It also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, BSN, Isopure, Nutramino, ABB, thinkThin, Amazing Grass, Body & Fit, and SlimFast brands in approximately 100 countries. The company was founded in 1964 and is headquartered in Kilkenny, Ireland.
Read More
Glanbia logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.32 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Sub-IndustryN/A
SectorConsumer Staples
Current SymbolOTCMKTS:GLAPY
Previous SymbolOTC:GLAPY
CUSIPN/A
CIKN/A
Webwww.glanbia.com
Phone353-56-777-2200

Debt

Debt-to-Equity Ratio0.30
Current Ratio1.23
Quick Ratio0.76

Price-To-Earnings

Trailing P/E Ratio10.34
Forward P/E Ratio12.75
P/E GrowthN/A

Sales & Book Value

Annual Sales$4.34 billion
Price / Sales0.70
Cash Flow$6.25 per share
Price / Cash Flow8.16
Book Value$32.19 per share
Price / Book1.58

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees7,385
Outstanding Shares59,209,000
Market Cap$3.02 billion
Next Earnings DateN/A
OptionableNot Optionable
$51.00
0.00 (0.00 %)
(As of 09/18/2020 08:10 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GLAPY News and Ratings via Email

Sign-up to receive the latest news and ratings for GLAPY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Glanbia (OTCMKTS:GLAPY) Frequently Asked Questions

How has Glanbia's stock been impacted by COVID-19 (Coronavirus)?

Glanbia's stock was trading at $57.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GLAPY stock has decreased by 11.4% and is now trading at $51.00.
View which stocks have been most impacted by COVID-19.

Are investors shorting Glanbia?

Glanbia saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 300 shares, a decrease of 40.0% from the August 15th total of 500 shares. Based on an average daily trading volume, of 5,700 shares, the days-to-cover ratio is presently 0.1 days.
View Glanbia's Short Interest.

Who are some of Glanbia's key competitors?

Some companies that are related to Glanbia include ATLANTIA SPA/ADR (ATASY), CHOW TAI FOOK J/ADR (CJEWY), CARREFOUR SA/S (CRRFY), Sonic Healthcare (NNGRY), Pernod Ricard (DVDCF), EDENRED S A/ADR (EDNMY), SEGRO (SEGXF), DAVIDE CAMPARI-/S (DVDCY), BRAMBLES LTD/S (BXBLY), AJINOMOTO INC/ADR (AJINY), Halma (HLMAF), Recordati (RCDTF), Air China (AIRYY), Bureau Veritas (BVRDF) and SAGE GRP PLC/GDR (SGPYY).
View all competitors.

Who are Glanbia's key executives?

Glanbia's management team includes the following people:
  • Ms. Siobhán Talbot, Group MD & Exec. Director (Age 55)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 55)
  • Mr. Brian Phelan, Exec. Director & CEO of Glanbia Nutritionals (Age 52)
  • Mr. Hugh McGuire, Exec. Director & CEO of Glanbia Performance Nutrition (Age 48)
  • Mr. Liam Hennigan, Group Director of Strategic Planning & Investor Relations

What is Glanbia's stock symbol?

Glanbia trades on the OTCMKTS under the ticker symbol "GLAPY."

How do I buy shares of Glanbia?

Shares of GLAPY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Glanbia's stock price today?

One share of GLAPY stock can currently be purchased for approximately $51.00.

How big of a company is Glanbia?

Glanbia has a market capitalization of $3.02 billion and generates $4.34 billion in revenue each year. The company earns $201.82 million in net income (profit) each year or $4.93 on an earnings per share basis. Glanbia employs 7,385 workers across the globe.

What is Glanbia's official website?

The official website for Glanbia is www.glanbia.com.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House Ring Road, KILKENNY L2, R95 E866. The company can be reached via phone at 353-56-777-2200 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.